Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Democratic Sweep Sets Stage for More Pharma Oversight
Democrats won big Tuesday on promises to make American life more affordable, particularly health care costs, but the market was unconvinced that policies will dramatically change pharma fortunes. Policy experts expect that Democrats will build on…
Nikkei Rises 0.7%, Led by Auto, Pharma Stocks
0019 GMT — Japanese stocks are higher after the Democratic sweep of U.S. Congress boosted expectations for a quick end to the Iran conflict, leading to sharply lower oil prices overnight. Auto, pharmaceutical and real-estate stocks are…
Alembic Pharma Q2 net surges 81% to ₹335 crore
Published - November 05, 2026 04:50 pm IST - HYDERABAD Subscribe to The Hindu @ Just ₹1* Subscribe to The Hindu @ Just $4.99 *Offer only for new subscribers Alembic Pharmaceuticals shares were in the spotlight Wednesday after the generic…
Royalty Pharma (RPRX) Q3 2026 Earnings Call Transcript
Chief Executive Officer and Chairman of the Board - Pablo Legorreta EVP, Head of Research and Investments - Marshall Urist EVP, Chief Financial Officer - Terry Coyne Senior Vice President, Head of Investor Relations and Communications - George…
Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue
Updated - November 05, 2026 05:04 pm IST - HYDERABAD Subscribe to The Hindu @ Just ₹1* Subscribe to The Hindu @ Just $4.99 *Offer only for new subscribers Aurobindo Pharma's consolidated net profit for the quarter ended September rose 32.5%…
Sun Pharma Shares Slip Below 20-Day EMA, Economic Times Reports
A price mismatch on The Economic Times' live page complicates its report that Sun Pharmaceutical Industries Limited shares traded beneath a 20-day EMA in early Thursday trading. At 11:06:05 p.m. EST Wednesday (04:06 UTC Thursday), The Economic…
Aurobindo Pharma Sets Quarterly Revenue Record as Q2 Profit Rises 32.5%
Aurobindo Pharma's revenue from operations reached ₹102.63 billion in the three months ended Sept. 30, 2026, a 23.9% annual increase and a new quarterly high, as consolidated profit after tax rose 32.5%. The company's unaudited results cover…
India's Aurobindo Pharma's quarterly profit rises by a third on strong US demand
By Thomson Reuters Nov 4, 2026 | 10:27 AM Nov 4 (Reuters) – Indian drugmaker Aurobindo Pharma reported a nearly 33% rise in second-quarter profit on Wednesday, led by strong demand and volume gains in its US market. •…
Swiss chikungunya fever patients live in close proximity
It is possible that two of the four patients were infected by the same mosquito, the Ticino cantonal medical officer stated in response to an enquiry from the Keystone-SDA news agency. The others were most likely bitten by related mosquitoes.
Aurobindo Pharma's Q2 FY27 net up 32% at ₹1124 cr
Updated - November 04, 2026 at 08:57 PM. Aurobindo Phama's consolidated net profit increased 32.5 per cent at ₹1,124 crore in the second quarter of the current financial year ended September 30, 2026, compared to ₹848 crore in the…
Nuvectis Pharma Q3 Earnings Call Highlights
Nuvectis Pharma NASDAQ: NVCT said its third quarter marked a strategic shift into late-stage development following a licensing agreement with Haisco for ex-China rights to two drug candidates: ciprocopan, also known as NXP100, and NXP200. Chairman…
Astellas Pharma (OTCMKTS:ALPMY) Issues Quarterly Earnings Results
Astellas Pharma (OTCMKTS:ALPMY - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by ($0.06), Zacks reports. Astellas…
Urogen Pharma (NASDAQ:URGN) Shares Down 16.3% on Disappointing Earnings
Urogen Pharma (NASDAQ:URGN - Get Free Report)'s stock price dropped 16.3% on Wednesday following a dissappointing earnings announcement. The stock traded as low as $29.35 and last traded at $28.80. 252,768 shares changed hands during trading, a…
Urogen Pharma (NASDAQ:URGN) Posts Earnings Results, Misses Estimates By $0.14 EPS
Urogen Pharma (NASDAQ:URGN - Get Free Report) released its earnings results on Wednesday. The company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of $0.11 by ($0.14), FiscalAI reports. The firm had revenue of $89.00…
Stocks in focus, Nov 5: Alembic Pharma, Northern Arc, V2 Retail, Cupid, NALCO, Bright Outdoor, Som Distilleries, Manipal Health
Alembic Pharmaceuticals Ltd has announced the expansion of its strategic collaboration with DifGen Pharmaceuticals. Building on their existing relationship, including the joint venture in Canada, the expanded collaboration combines DifGen's…
Receive a Daily briefing on Pharma Industry News
Get Started